The Charger Bulletin

FDA Reviews 2 New Drugs to Reduce Prostate Cancer

The Associated Press December 1, 2010

WASHINGTON – Health regulators said Monday that two drugs from GlaxoSmithKline and Merck reduce the risk of prostate cancer in men, though scientists questioned the drugs’ overall benefit, since the...

Load More Stories
Activate Search
Merck